Advancing Personalized Medicine

The global fight against cancer requires personalized molecular detection tools to get the right answer the first time.

What We Do

One source for detecting genetic variations associated with cancers and inherited diseases.

ArcherDX, Inc. addresses the bottlenecks associated with using next-generation sequencing (NGS) by offering a robust platform for targeted sequencing applications. Improve the speed and accuracy of genetic variant identification and discovery using Archer® patented technology.

Learn More About ArcherDX

Simply Solving the Most

Complex Genomic Problems

Archer patented Anchored Multiplex PCR (AMP™) technology enables:

Novel Gene Fusion Detection
Sensitive Variant Detection
Robust CNV and Expression Information
Fast Turn-Around Time

You are now leaving Links to sites outside of ArcherDX are provided as a resource to the viewer. ArcherDX accepts no responsibility for the content of linked sites. 

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.

We won’t track your information when you visit our site. But in order to comply with your preferences, we’ll have to use just one tiny cookie so that you’re not asked to make this choice again.